Zobrazeno 1 - 10
of 28
pro vyhledávání: '"l. V. Fedina"'
Autor:
l. V. Fedina, i. N. Sychev, K. V. Mirzaev, A. V. Vardanyan, S. V. Glagolev, A. A. Kachanova, P. O. Bochkov, R. V. Shevchenko, S. N. Tuchkova, I. V. Sychev, S. P. Abdullaev, D A. Sychev
Publikováno v:
Рациональная фармакотерапия в кардиологии, Vol 20, Iss 1, Pp 19-26 (2024)
Aim. The aim of our study was to investigate the influence of polymorphic markers of CYP3A4*22 CYP3A4*22 (c.522-191C>T, rs35599367), CYP3A5*3 (c.219237A>G, rs776746), ABCB1 rs1045642 (c.3435T>C) and rs4148738 (c.2692-2236C>T) genes on the plasma conc
Externí odkaz:
https://doaj.org/article/895693a579cb4ad08184d9190f32a514
Autor:
I. N. Sychev, O. V. Ignatenko, S. V. Yakovlev, L. V. Fedina, E. N. Burmistrova, M. P. Suvorova, T. D. Rastvorova, E. V. Strigunkova, R. Kh. Mukhamadiev
Publikováno v:
Вестник анестезиологии и реаниматологии, Vol 21, Iss 1, Pp 24-34 (2024)
The objective was to study the risk factors, outcomes of infections caused by colistin-resistant K. pneumonia (CRKP) and to evaluate the sensitivity of these microorganisms to antibacterial agents to determine the most adequate antibiotic therapy opt
Externí odkaz:
https://doaj.org/article/29b1313ed1f545109536c7393ba3024f
Autor:
O. A. Kupriushina, D. A. Strelkova, A. S. Yasneva, S. A. Rachina, S. N. Avdeev, A. E. Vlasenko, L. V. Fedina, O. V. Ivanova, I. V. Kaledina, N. A. Ananicheva
Publikováno v:
Качественная клиническая практика, Vol 0, Iss 4, Pp 78-85 (2024)
Relevance. During and after the COVID-19 pandemic, viruses have become a more common cause of pulmonary infections in adults; therefore, the distinction between viral lung injury and community-acquired bacterial pneumonia is of increasing importance.
Externí odkaz:
https://doaj.org/article/96be733286ee41cfbe6ebb0051e56f30
Autor:
M. P. Suvorova, I. N. Sychev, O. V. Ignatenko, E. N. Burmistrova, S. S. Mirzakhamidova, L. V. Fedina, R. M. Vakolyuk, S. V. Yakovlev
Publikováno v:
Антибиотики и Химиотерапия, Vol 67, Iss 11-12, Pp 36-45 (2023)
Background. The difficulties of antibacterial therapy of infections caused by carbapenemase-producing gram-negative bacteria are associated with limited options for adequate therapy since, in addition to resistance to carbapenems and other beta-lacta
Externí odkaz:
https://doaj.org/article/6402443bc6a64d529baf12b520ab08d8
Autor:
L. V. Fedina, I. N. Sychev, T. D. Rastvorova, E. V. Strigunkova, A. A. Kachanova, Z. A. Sozaeva, P. O. Bochkov, A. V. Vardanyan, K. B. Mirzayev, D. A. Sychev
Publikováno v:
Рациональная фармакотерапия в кардиологии, Vol 18, Iss 6, Pp 624-629 (2023)
Aim. To investigate the effect of ABCB1 gene carriage and interdrug interactions on apixaban pharmacokinetics and clinical outcomes in patients with atrial fibrillation and deep vein thrombosis.Material and methods. Patients hospitalized at Yudin Sta
Externí odkaz:
https://doaj.org/article/547d7b56152449b99e64946f0dcd6d76
Autor:
D. V. Ivaschenko, L. V. Fedina, N. I. Buromskaya, P. V. Shimanov, R. V. Deitsch, M. I. Nastovich, K. A. Akmalova, A. A. Kachanova, E. A. Grishina, L. M. Savchenko, Y. S. Shevchenko, D. A. Sychev
Publikováno v:
Качественная клиническая практика, Vol 0, Iss 2, Pp 78-88 (2021)
Introduction. Antipsychotics are the main drugs for treatment of schizophrenia spectrum disorders. Pharmacodynamic genetic factors are being actively studied to improve the accuracy of antipsychotic selection based on pharmacogenetic testing. Purpose
Externí odkaz:
https://doaj.org/article/482e62160ac840f6a9c671c232303e4f
Publikováno v:
Obrazovanie i Nauka, Vol 23, Iss 4, Pp 43-78 (2021)
Introduction. In the 21st century, there is an active involvement of universities in inclusive processes; however, against the backdrop of increasing diversity, new types of inequality arise in higher education. The processes of transformation of org
Externí odkaz:
https://doaj.org/article/9cbf2f10a67a4c50933f7b7a8ee69262
Autor:
I. N. Sychev, L. V. Fedina, A. S. Osipov, I. I. Temirbulatov, O. Yu. Tataroy, Zh. A. Sozaeva, K. A. Akmalova, N. P. Denisenko, S. P. Abdullaev, A. A. Kachanova, E. A. Grishina, K. B. Mirzaev, D. A. Sychev
Publikováno v:
Медицинский совет, Vol 0, Iss 4, Pp 41-46 (2021)
Introduction. Apixaban is a direct oral anticoagulant prescribed for treatment and prevention of venous thromboembolism (VTE) and for prevention of stroke in patients with nonvalvular atrial fibrillation. Direct oral anticoagulants (DOACs) such as ap
Externí odkaz:
https://doaj.org/article/5ad7ad0be6504c7ca0446a126b130503
Publikováno v:
Obrazovanie i Nauka, Vol 22, Iss 5, Pp 111-131 (2020)
Introduction.The preservation and well-being of the indigenous peoples of the Russian North is directly related to the national identity, the values for sustaining vital activities, the continuation and development of traditional crafts. Thus, the pr
Externí odkaz:
https://doaj.org/article/df7bd62d820a43729d3de1182d04befe
Autor:
I. N. Sychev, L. V. Fedina, D. A. Gabrielyan, T. D. Rastvorova, E. V. Strigunkova, K. B. Mirzayev, D. A. Sychev
Publikováno v:
Meditsinskiy sovet = Medical Council. :52-64
Cardiovascular disease is the most common cause of death in the world. For almost 60 years vitamin K antagonists (VKAs) have been the mainstay of anticoagulant therapy, but in recent years direct oral anticoagulants (DAACs) have become the anticoagul